Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference-Reference-Cited by-同舟云学术

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference

Published:2023-04-22 Issue:6 Volume:25 Page:309-321
ISSN:1523-3804
Container-title:Current Atherosclerosis Reports
language:en
Short-container-title:Curr Atheroscler Rep

Author:

Gupta Kartik^ORCID,Balachandran Isabel,Foy Jacob,Hermel Melody,Latif Azka,Krittanawong Chayakrit,Slipczuk Leandro,Baloch Farhala,Samad Zainab,Virani Salim S.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11883-023-01103-4.pdf

Reference18 articles.

1. Gupta K, Hirsch JR, Kalsi J, Patel V, Gad MM, Virani SS. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2023;25(1):31–41. https://doi.org/10.1007/s11883-022-01079-7.

2. Hermel M, Tsai S, Dlouhy L, et al. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American College of Cardiology Scientific Sessions. Curr Atheroscler Rep. 2022;24(8):671–80. https://doi.org/10.1007/s11883-022-01042-6.

3. Bytyçi I, Penson PE, Mikhailidis DP, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213–23. https://doi.org/10.1093/eurheartj/ehac015.

4. Virani SS, Ballantyne CM, Petersen LA. Guideline-Concordant Statin Therapy Use in Secondary Prevention: Should the Medical Community Wait for Divine Intervention? J Am Coll Cardiol. 2022;79(18):1814–7. https://doi.org/10.1016/j.jacc.2022.02.042.

5. • Nelson AJ, Haynes K, Shambhu S, et al. High-Intensity Statin Use Among Patients With Atherosclerosis in the US. J Am Coll Cardiol. 2022;79(18):1802–13. https://doi.org/10.1016/j.jacc.2022.02.048. Highlights significant gap in prescription of statins for secondary prevention in the US in a contemporary cohort of patients enrolled in a commercial health plan.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring?;Current Atherosclerosis Reports;2024-08-16

2. Variability of Mitochondrial DNA Heteroplasmy: Association with Asymptomatic Carotid Atherosclerosis;Biomedicines;2024-08-15

3. Comprehensive review of statin-intolerance and the practical application of Bempedoic Acid;Journal of Cardiology;2024-07

4. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference;Current Atherosclerosis Reports;2024-06-03

5. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions;Current Atherosclerosis Reports;2024-03-05